Cholecystitis (Acalculous)

1. Comprehensive Introduction & Overview

Acalculous cholecystitis (AC) represents a distinct, highly morbid clinical entity characterized by acute inflammation of the gallbladder in the absence of gallstones (cholelithiasis). Unlike calculous cholecystitis, which is typically a disease of the ambulatory population associated with biliary colic, acalculous cholecystitis is predominantly a disease of the critically ill. It is frequently encountered in intensive care unit (ICU) settings, following major trauma, extensive surgery, or prolonged parenteral nutrition.

Because it occurs in patients who are often sedated, ventilated, or suffering from multi-system organ failure, the clinical presentation is frequently masked, leading to diagnostic delays. This delay is catastrophic, as acalculous cholecystitis is associated with a significantly higher rate of gangrene, perforation, and mortality (ranging from 10% to 50%) compared to its calculous counterpart.

2. Deep-Dive: Mechanisms and Pathophysiology

The pathophysiology of acalculous cholecystitis is complex and multifactorial, primarily centered on the triad of bile stasis, gallbladder ischemia, and mucosal injury.

The Triad of Pathogenesis

• Bile Stasis: In critically ill patients, the lack of enteral feeding leads to a decrease in cholecystokinin (CCK) release. Without CCK, the gallbladder fails to contract, leading to prolonged bile stasis. This stagnant bile becomes concentrated, increasing the risk of "sludge" formation, which can obstruct the cystic duct.
• Gallbladder Ischemia: The cystic artery is an end-artery with minimal collateral circulation. In states of systemic hypotension, shock, or vasopressor use, the gallbladder is highly susceptible to hypoperfusion. Ischemic injury to the gallbladder wall leads to mucosal barrier breakdown.
• Mucosal Injury and Inflammation: Once the barrier is compromised, concentrated bile salts, lysolecithin, and inflammatory mediators (such as prostaglandins) penetrate the wall, triggering an intense inflammatory response, edema, and secondary bacterial infection.

Contributing Factors

3. Clinical Indications and Diagnostic Protocol

Standard Presentation

The classic clinical triad of right upper quadrant (RUQ) pain, fever, and leukocytosis is present in fewer than 30% of patients with acalculous cholecystitis. In the ICU, the clinician must maintain a high index of suspicion for any patient who develops:
1. Unexplained sepsis or SIRS (Systemic Inflammatory Response Syndrome).
2. Unexplained jaundice or abnormal liver function tests (LFTs).
3. Right upper quadrant tenderness (often elicitable only on deep palpation).
4. A palpable mass in the RUQ (indicating potential hydrops or gangrene).

Diagnostic Hierarchy (The Imaging Gold Standard)

Diagnosis relies heavily on imaging due to the unreliability of physical examinations in the critical care population.

1. Ultrasonography (US): The first-line modality. Key findings include gallbladder wall thickening (>3mm), pericholecystic fluid, intramural gas (emphysematous cholecystitis), and the "sonographic Murphy’s sign."
2. Computed Tomography (CT): Often superior in the ICU setting as it can evaluate for other abdominal pathology simultaneously. Findings include gallbladder distension, wall enhancement, and pericholecystic fat stranding.
3. Hepatobiliary Iminodiacetic Acid (HIDA) Scan: If imaging is equivocal, a HIDA scan is the diagnostic gold standard. Failure of the gallbladder to visualize after the administration of CCK or morphine augmentation strongly suggests cystic duct obstruction or acalculous cholecystitis.

4. Risks, Staging, and Prognosis

Clinical Staging

While there is no formal TNM-style staging, clinicians categorize the severity to determine the urgency of intervention:
* Grade I (Mild): Acute cholecystitis in a patient without organ dysfunction.
* Grade II (Moderate): Associated with leukocytosis (>18,000/mm³), palpable mass, or duration >72 hours.
* Grade III (Severe): Associated with organ failure (cardiovascular, neurological, respiratory, renal, hepatic, or hematological).

Long-term Prognosis

The prognosis is dictated more by the underlying comorbid condition than by the gallbladder pathology itself. However, mortality remains high if cholecystectomy or decompression is delayed. Patients who survive the acute episode rarely experience recurrence, as the etiology is transient (e.g., the period of critical illness).

Risks of Delay

• Gangrenous Cholecystitis: Necrosis of the gallbladder wall.
• Perforation: Leading to localized abscess or generalized biliary peritonitis.
• Emphysematous Cholecystitis: A gas-forming bacterial infection, often seen in diabetics, requiring emergent surgery.

5. Management Strategies

The treatment approach is stratified based on the patient's surgical risk.

• Percutaneous Cholecystostomy (PC): The treatment of choice for critically ill, unstable patients. A drain is placed into the gallbladder under ultrasound or CT guidance to decompress the organ. This is a bridge to surgery or, in some cases, the definitive treatment.
• Cholecystectomy: Open or laparoscopic cholecystectomy is reserved for patients who are stable enough to undergo general anesthesia. Laparoscopic surgery is preferred, but open surgery may be necessary if there is extensive pericholecystic inflammation or anatomical distortion.
• Antibiotic Therapy: Empiric coverage should target common enteric organisms (E. coli, Klebsiella, Enterococcus).

6. Frequently Asked Questions (FAQ)

1. How is acalculous cholecystitis different from typical gallstone-related cholecystitis?
Acalculous cholecystitis occurs without stones and is primarily a complication of systemic critical illness. It has a significantly higher mortality rate due to delayed diagnosis.

2. Why is physical examination often misleading?
Many patients are sedated, intubated, or have altered mental status, rendering the standard Murphy's sign and abdominal guarding difficult to assess.

3. What is the role of the HIDA scan?
The HIDA scan assesses the patency of the cystic duct. If the gallbladder does not fill with the radiotracer, it confirms obstruction or severe inflammation.

4. When should a patient get a cholecystostomy tube?
A cholecystostomy tube is indicated for patients who are too unstable (e.g., on multiple vasopressors or in multi-organ failure) to tolerate surgery.

5. Is surgery always required?
Not always. In some cases, percutaneous drainage followed by stabilization of the underlying systemic condition is sufficient. However, if the gallbladder remains a source of sepsis, interval cholecystectomy is recommended once the patient is stable.

6. Can TPN cause this condition?
Yes. Prolonged TPN causes gallbladder stasis because the lack of enteral stimulation prevents the release of CCK, which is necessary for gallbladder contraction.

7. How common is emphysematous cholecystitis in the acalculous population?
It is more common in acalculous patients than in calculous patients, particularly in elderly diabetics, and represents a surgical emergency.

8. What is the "sonographic Murphy's sign"?
It is the elicitation of maximal tenderness directly over the gallbladder during ultrasound probe compression.

9. Why is the cystic artery important?
The cystic artery is an end-artery. When the patient is in shock, blood flow to the gallbladder is sacrificed to prioritize vital organs, leading to ischemia and necrosis.

10. What is the mortality rate for acalculous cholecystitis?
Mortality varies between 10% and 50% depending on the severity of the associated systemic disease and the speed of intervention.

7. Conclusion: Clinical Pearls for the Specialist

As an orthopedic or clinical specialist, you must recognize that acalculous cholecystitis is a "silent killer" in the post-operative recovery phase. Any patient who is not recovering as expected, or who develops unexplained fever or "ileus-like" symptoms following major surgery, should undergo a RUQ ultrasound. Never assume that the absence of gallstones rules out gallbladder disease in a patient with systemic inflammation. Early identification through high-resolution imaging and prompt consultation with interventional radiology or general surgery is the only way to mitigate the significant morbidity associated with this diagnosis.